1. Home
  2. YMT vs ALZN Comparison

YMT vs ALZN Comparison

Compare YMT & ALZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Yimutian Inc. American Depositary Shares

YMT

Yimutian Inc. American Depositary Shares

HOLD

Current Price

$0.49

Market Cap

3.8M

Sector

Technology

ML Signal

HOLD

Logo Alzamend Neuro Inc.

ALZN

Alzamend Neuro Inc.

HOLD

Current Price

$1.32

Market Cap

4.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
YMT
ALZN
Founded
2011
2016
Country
China
United States
Employees
673
N/A
Industry
EDP Services
Medicinal Chemicals and Botanical Products
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.8M
4.6M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
YMT
ALZN
Price
$0.49
$1.32
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$28.00
AVG Volume (30 Days)
264.4K
133.1K
Earning Date
06-09-2026
03-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
22.99
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.12
$0.84
52 Week High
$2.85
$3.14

Technical Indicators

Market Signals
Indicator
YMT
ALZN
Relative Strength Index (RSI) 41.99 63.15
Support Level $0.40 $1.04
Resistance Level $0.63 $2.25
Average True Range (ATR) 0.06 0.11
MACD 0.00 0.01
Stochastic Oscillator 23.76 89.69

Price Performance

Historical Comparison
YMT
ALZN

About YMT Yimutian Inc. American Depositary Shares

Yimutian Inc operates an agricultural B2B platform in China. It provides a comprehensive set of digital solutions to facilitate agricultural product transactions, ranging from searching and matching to transaction facilitation and settlement, through its Yimutian App and Douniu App. Additionally, leveraging its industry experience and market insights, the company has ventured into the realm of smart farming and agricultural sourcing and trading, further broadening its commercialization channels and animating its other business lines. The company operates as a single operating and reportable segment, as it offers a unified set of products and services mainly related to the provision of digital agricultural transaction services.

About ALZN Alzamend Neuro Inc.

Alzamend Neuro Inc is an early clinical-stage biopharmaceutical company. It is focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders, including Alzheimer's. Its mission is to develop and market safe and effective treatments. The company's pipeline consists of two novel therapeutic drug candidates, AL001 - a patented ionic cocrystal technology delivering lithium via a therapeutic combination of lithium, proline and salicylate, and AL002 - a patented method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine that seeks to restore the ability of a patient's immunological system to combat Alzheimer's.

Share on Social Networks: